IGC IGC Pharma, Inc.
$0.25▼ -0.80%
Healthcare
Other
After hours
$0.25▲ +1.98%
Oct 27, 5:48 PM ET
Volume 118.3K
Avg Volume (10D) 453.6K
Key Metrics & Fundamentals
Market Cap
$25.63M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.24 - 0.45
% vs 50 MA
-10.83%
% vs 200 MA
-11.87%
RSI-14
38.9
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.82
Free Cash Flow
-$1.39M
Gross Rev
$317,000
Gross Profit
$55,000
EBITDA
-$2.40M
COGS
$262,000
Operating Exp
$2.51M
Operating Income
-$2.46M
EBIT
-$2.46M
Pretax Income
-$2.40M
Net Income
-$2.40M
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News
IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment
ACCESS Newswire · Oct 13, 2026 8:00 AM ET
IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
ACCESS Newswire · Sep 28, 2026 8:00 AM ET
IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure
ACCESS Newswire · Aug 17, 2026 8:30 AM ET
IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout
ACCESS Newswire · Aug 11, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2026
See IGC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.